CMBA
VIR icon

C.M. Bidwell & Associates’s Vir Biotechnology VIR Stock Holding History

C.M. Bidwell & Associates’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-641
Closed -$4.15K – 497
2025
Q1 		$4.15K Buy
+641
New +$5.7K ﹤0.01% 327
2024
Q3 		– Sell
-360
Closed -$3.2K – 547
2024
Q2 		$3.2K Sell
360
-41
-10% -$393 ﹤0.01% 373
2024
Q1 		$4.06K Buy
+401
New +$4.08K ﹤0.01% 343
2023
Q3 		– Sell
-2,423
Closed -$59.4K – 603
2023
Q2 		$59.4K Buy
+2,423
New +$60.8K 0.04% 277

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return